ID   CARM1_RAT               Reviewed;         651 AA.
AC   Q4AE70; Q4AE68; Q4AE69; Q4AE71;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   02-OCT-2024, entry version 152.
DE   RecName: Full=Histone-arginine methyltransferase CARM1;
DE            EC=2.1.1.319 {ECO:0000250|UniProtKB:Q9WVG6};
DE   AltName: Full=Coactivator-associated arginine methyltransferase 1;
DE   AltName: Full=Protein arginine N-methyltransferase 4;
GN   Name=Carm1; Synonyms=Prmt4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), FUNCTION (ISOFORM 3),
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND INTERACTION WITH SNRPC.
RC   TISSUE=Fetal brain;
RX   PubMed=15944154; DOI=10.1074/jbc.m502173200;
RA   Ohkura N., Takahashi M., Yaguchi H., Nagamura Y., Tsukada T.;
RT   "Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-
RT   mRNA splicing in an isoform-specific manner.";
RL   J. Biol. Chem. 280:28927-28935(2005).
RN   [2]
RP   FUNCTION IN METHYLATION OF ELAV4, AND SUBCELLULAR LOCATION.
RX   PubMed=16508003; DOI=10.1128/mcb.26.6.2273-2285.2006;
RA   Fujiwara T., Mori Y., Chu D.L., Koyama Y., Miyata S., Tanaka H., Yachi K.,
RA   Kubo T., Yoshikawa H., Tohyama M.;
RT   "CARM1 regulates proliferation of PC12 cells by methylating HuD.";
RL   Mol. Cell. Biol. 26:2273-2285(2006).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 28-507 IN COMPLEX WITH
RP   S-ADENOSYL-L-HOMOCYSTEINE, SUBUNIT, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17882262; DOI=10.1038/sj.emboj.7601855;
RA   Troffer-Charlier N., Cura V., Hassenboehler P., Moras D., Cavarelli J.;
RT   "Functional insights from structures of coactivator-associated arginine
RT   methyltransferase 1 domains.";
RL   EMBO J. 26:4391-4401(2007).
CC   -!- FUNCTION: Methylates (mono- and asymmetric dimethylation) the guanidino
CC       nitrogens of arginyl residues in several proteins involved in DNA
CC       packaging, transcription regulation, pre-mRNA splicing, and mRNA
CC       stability (PubMed:16508003). Recruited to promoters upon gene
CC       activation together with histone acetyltransferases from EP300/P300 and
CC       p160 families, methylates histone H3 at 'Arg-17' (H3R17me), forming
CC       mainly asymmetric dimethylarginine (H3R17me2a), leading to activation
CC       of transcription via chromatin remodeling (By similarity). During
CC       nuclear hormone receptor activation and TCF7L2/TCF4 activation, acts
CC       synergically with EP300/P300 and either one of the p160 histone
CC       acetyltransferases NCOA1/SRC1, NCOA2/GRIP1 and NCOA3/ACTR or
CC       CTNNB1/beta-catenin to activate transcription (By similarity). During
CC       myogenic transcriptional activation, acts together with NCOA3/ACTR as a
CC       coactivator for MEF2C (By similarity). During monocyte inflammatory
CC       stimulation, acts together with EP300/P300 as a coactivator for NF-
CC       kappa-B (By similarity). Acts as a coactivator for PPARG, promotes
CC       adipocyte differentiation and the accumulation of brown fat tissue (By
CC       similarity). Plays a role in the regulation of pre-mRNA alternative
CC       splicing by methylation of splicing factors (By similarity). Also seems
CC       to be involved in p53/TP53 transcriptional activation (By similarity).
CC       Methylates EP300/P300, both at 'Arg-2142', which may loosen its
CC       interaction with NCOA2/GRIP1, and at 'Arg-580' and 'Arg-604' in the KIX
CC       domain, which impairs its interaction with CREB and inhibits CREB-
CC       dependent transcriptional activation (By similarity). Also methylates
CC       arginine residues in RNA-binding proteins PABPC1, ELAVL1 and ELAV4,
CC       which may affect their mRNA-stabilizing properties and the half-life of
CC       their target mRNAs (PubMed:16508003). Acts as a transcriptional
CC       coactivator of ACACA/acetyl-CoA carboxylase by enriching H3R17
CC       methylation at its promoter, thereby positively regulating fatty acid
CC       synthesis (By similarity). Independently of its methyltransferase
CC       activity, involved in replication fork progression: promotes PARP1
CC       recruitment to replication forks, leading to poly-ADP-ribosylation of
CC       chromatin at replication forks and reduced fork speed (By similarity).
CC       {ECO:0000250|UniProtKB:Q86X55, ECO:0000250|UniProtKB:Q9WVG6,
CC       ECO:0000269|PubMed:16508003}.
CC   -!- FUNCTION: [Isoform 3]: Isoform 3 specifically affects pre-mRNA splicing
CC       (PubMed:15944154). This activity is independent from methyltransferase
CC       activity (PubMed:15944154). {ECO:0000269|PubMed:15944154}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-arginyl-[protein] + 2 S-adenosyl-L-methionine = 2 H(+) +
CC         N(omega),N(omega)-dimethyl-L-arginyl-[protein] + 2 S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:48096, Rhea:RHEA-COMP:10532, Rhea:RHEA-
CC         COMP:11991, ChEBI:CHEBI:15378, ChEBI:CHEBI:29965, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61897; EC=2.1.1.319;
CC         Evidence={ECO:0000250|UniProtKB:Q9WVG6};
CC   -!- ACTIVITY REGULATION: Methylation of H3R17 (H3R17me) by CARM1 is
CC       stimulated by preacetylation of H3 'Lys-18' (H3K18ac) H3 'Lys-23'
CC       (H3K23ac) by EP300 and blocked by citrullination of H3 'Arg-17'
CC       (H3R17ci) by PADI4. {ECO:0000250|UniProtKB:Q9WVG6}.
CC   -!- SUBUNIT: Homodimer (PubMed:17882262). Interacts with NR1H4 (By
CC       similarity). Interacts with SNRPC (PubMed:15944154). Interacts with the
CC       C-terminus of NCOA2/GRIP1, NCO3/ACTR and NCOA1/SRC1. Part of a complex
CC       consisting of CARM1, EP300/P300 and NCOA2/GRIP1. Interacts with FLII,
CC       TP53, myogenic factor MEF2, EP300/P300, TRIM24, CREBBP and CTNNB1.
CC       Interacts with RELA. Identified in a complex containing CARM1, TRIM24
CC       and NCOA2/GRIP1. Interacts with NCOA3/SRC3. Interacts with SKP2.
CC       Interacts (via PH domain-like fold) with C9orf72 (By similarity).
CC       Interacts with PARP1; promoting PARP1 recruimtent to replication forks
CC       (By similarity). {ECO:0000250|UniProtKB:Q86X55,
CC       ECO:0000250|UniProtKB:Q9WVG6, ECO:0000269|PubMed:15944154,
CC       ECO:0000269|PubMed:17882262}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16508003}. Cytoplasm
CC       {ECO:0000269|PubMed:16508003}. Chromosome
CC       {ECO:0000250|UniProtKB:Q86X55}. Note=Mainly nuclear during the G1, S
CC       and G2 phases of the cell cycle. Cytoplasmic during mitosis, after
CC       breakup of the nuclear membrane. Localizes to replication forks.
CC       {ECO:0000250|UniProtKB:Q86X55}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Named isoforms=2.;
CC       Name=1; Synonyms=CARM1-v2 {ECO:0000303|PubMed:15944154};
CC         IsoId=Q4AE70-1; Sequence=Displayed;
CC       Name=2; Synonyms=CARM1-v1 {ECO:0000303|PubMed:15944154};
CC         IsoId=Q4AE70-2; Sequence=VSP_020384;
CC       Name=3; Synonyms=CARM1-v3 {ECO:0000303|PubMed:15944154};
CC         IsoId=Q4AE70-3; Sequence=VSP_020382, VSP_020385;
CC       Name=4; Synonyms=CARM1-v4 {ECO:0000303|PubMed:15944154};
CC         IsoId=Q4AE70-4; Sequence=VSP_020383;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Isoform 1 is expressed at low levels
CC       in brain, liver and testis. {ECO:0000269|PubMed:15944154}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Isoform 2 is highly expressed in
CC       brain, liver, skeletal muscle and testis.
CC       {ECO:0000269|PubMed:15944154}.
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: Isoform 3 is highly expressed in
CC       spleen, liver and kidney. {ECO:0000269|PubMed:15944154}.
CC   -!- TISSUE SPECIFICITY: [Isoform 4]: Isoform 4 is expressed in spleen,
CC       liver and kidney. {ECO:0000269|PubMed:15944154}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform 2]: Expressed in fetal brain.
CC       {ECO:0000269|PubMed:15944154}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform 3]: Expressed in fetal brain.
CC       {ECO:0000269|PubMed:15944154}.
CC   -!- PTM: Auto-methylated on Arg-551. Methylation enhances transcription
CC       coactivator activity. Methylation is required for its role in the
CC       regulation of pre-mRNA alternative splicing (By similarity).
CC       {ECO:0000250|UniProtKB:Q9WVG6}.
CC   -!- PTM: Phosphorylation at Ser-217 interferes with S-adenosyl-L-methionine
CC       binding and strongly reduces methyltransferase activity.
CC       Phosphorylation at Ser-217 is strongly increased during mitosis, and
CC       decreases rapidly to a very low, basal level after entry into the G1
CC       phase of the cell cycle. Phosphorylation at Ser-217 may promote
CC       location in the cytosol (By similarity). {ECO:0000250|UniProtKB:Q86X55,
CC       ECO:0000250|UniProtKB:Q9WVG6}.
CC   -!- PTM: Ubiquitinated by E3 ubiquitin-protein ligase complex containing
CC       FBXO9 at Lys-228; leading to proteasomal degradation.
CC       {ECO:0000250|UniProtKB:Q86X55}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. Protein arginine N-methyltransferase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01015}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB201114; BAE16333.1; -; mRNA.
DR   EMBL; AB201115; BAE16334.1; -; mRNA.
DR   EMBL; AB201116; BAE16335.1; -; mRNA.
DR   EMBL; AB201117; BAE16336.1; -; mRNA.
DR   RefSeq; NP_001025212.1; NM_001030041.3. [Q4AE70-2]
DR   RefSeq; NP_001029260.1; NM_001034088.2. [Q4AE70-4]
DR   PDB; 2OQB; X-ray; 1.69 A; A/B=28-140.
DR   PDB; 3B3F; X-ray; 2.20 A; A/B/C/D=140-480.
DR   PDB; 3B3G; X-ray; 2.40 A; A/B=140-480.
DR   PDB; 3B3J; X-ray; 2.55 A; A=28-507.
DR   PDBsum; 2OQB; -.
DR   PDBsum; 3B3F; -.
DR   PDBsum; 3B3G; -.
DR   PDBsum; 3B3J; -.
DR   AlphaFoldDB; Q4AE70; -.
DR   SMR; Q4AE70; -.
DR   IntAct; Q4AE70; 1.
DR   STRING; 10116.ENSRNOP00000042739; -.
DR   CarbonylDB; Q4AE70; -.
DR   GlyGen; Q4AE70; 1 site, 1 O-linked glycan (1 site).
DR   PhosphoSitePlus; Q4AE70; -.
DR   jPOST; Q4AE70; -.
DR   PaxDb; 10116-ENSRNOP00000042739; -.
DR   Ensembl; ENSRNOT00000041577.5; ENSRNOP00000049428.5; ENSRNOG00000031129.7. [Q4AE70-1]
DR   Ensembl; ENSRNOT00000048245.7; ENSRNOP00000042739.3; ENSRNOG00000031129.7. [Q4AE70-2]
DR   Ensembl; ENSRNOT00055022848; ENSRNOP00055018520; ENSRNOG00055013317. [Q4AE70-1]
DR   Ensembl; ENSRNOT00060052733; ENSRNOP00060043837; ENSRNOG00060030321. [Q4AE70-1]
DR   Ensembl; ENSRNOT00065020480; ENSRNOP00065015733; ENSRNOG00065012588. [Q4AE70-1]
DR   GeneID; 363026; -.
DR   KEGG; rno:363026; -.
DR   UCSC; RGD:1305879; rat. [Q4AE70-1]
DR   AGR; RGD:1305879; -.
DR   CTD; 10498; -.
DR   RGD; 1305879; Carm1.
DR   GeneTree; ENSGT00940000160377; -.
DR   HOGENOM; CLU_017375_0_1_1; -.
DR   InParanoid; Q4AE70; -.
DR   OMA; QFATPNX; -.
DR   OrthoDB; 197898at2759; -.
DR   PhylomeDB; Q4AE70; -.
DR   TreeFam; TF323332; -.
DR   Reactome; R-RNO-3214858; RMTs methylate histone arginines.
DR   Reactome; R-RNO-400206; Regulation of lipid metabolism by PPARalpha.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-RNO-9707564; Cytoprotection by HMOX1.
DR   EvolutionaryTrace; Q4AE70; -.
DR   PRO; PR:Q4AE70; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000031129; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0043596; C:nuclear replication fork; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0008469; F:histone arginine N-methyltransferase activity; ISO:RGD.
DR   GO; GO:0035642; F:histone H3R17 methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0070611; F:histone H3R2 methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0140903; F:histone H3R26 methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0042054; F:histone methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0008276; F:protein methyltransferase activity; ISO:RGD.
DR   GO; GO:0016274; F:protein-arginine N-methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; IBA:GO_Central.
DR   GO; GO:0060350; P:endochondral bone morphogenesis; ISO:RGD.
DR   GO; GO:0030520; P:estrogen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:2000171; P:negative regulation of dendrite development; IMP:RGD.
DR   GO; GO:0030518; P:nuclear receptor-mediated steroid hormone signaling pathway; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:1904037; P:positive regulation of epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0071168; P:protein localization to chromatin; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0003420; P:regulation of growth plate cartilage chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0071932; P:replication fork reversal; ISS:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IDA:RGD.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   CDD; cd02440; AdoMet_MTases; 1.
DR   CDD; cd13330; PH_CARM1; 1.
DR   Gene3D; 2.70.160.11; Hnrnp arginine n-methyltransferase1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR025799; Arg_MeTrfase.
DR   InterPro; IPR020989; Histone-Arg_MeTrfase_N.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR11006:SF51; HISTONE-ARGININE METHYLTRANSFERASE CARM1; 1.
DR   PANTHER; PTHR11006; PROTEIN ARGININE N-METHYLTRANSFERASE; 1.
DR   Pfam; PF11531; CARM1; 1.
DR   Pfam; PF06325; PrmA; 1.
DR   Pfam; PF22528; PRMT_C; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   PROSITE; PS51678; SAM_MT_PRMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator; Chromosome;
KW   Cytoplasm; Isopeptide bond; Methylation; Methyltransferase;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; S-adenosyl-L-methionine; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation.
FT   CHAIN           1..651
FT                   /note="Histone-arginine methyltransferase CARM1"
FT                   /id="PRO_0000249250"
FT   DOMAIN          147..454
FT                   /note="SAM-dependent MTase PRMT-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01015"
FT   REGION          28..139
FT                   /note="Interaction with C9orf72"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   REGION          347..380
FT                   /note="Required for nuclear translocation"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   REGION          500..651
FT                   /note="Transactivation domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   REGION          581..617
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        600..617
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         160
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:17882262"
FT   BINDING         169
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:17882262"
FT   BINDING         193
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:17882262"
FT   BINDING         215
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:17882262"
FT   BINDING         244
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:17882262"
FT   BINDING         272
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:17882262"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86X55"
FT   MOD_RES         551
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   CROSSLNK        228
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86X55"
FT   VAR_SEQ         540..643
FT                   /note="ANTGIVNHTHSRMGSIMSTGIVQGNRVAGPWAGDLPPGLRTRSSYQWGPGRL
FT                   RGHAGSSVPMTCPTGSSGAQGGGGSSSAHYAVNNQFTMGGPAISMASPMSIP -> GEC
FT                   PLGSMACQGRTGICQWPAKPVLGSLPPLSLS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15944154"
FT                   /id="VSP_020382"
FT   VAR_SEQ         540..605
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15944154"
FT                   /id="VSP_020383"
FT   VAR_SEQ         564..606
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15944154"
FT                   /id="VSP_020384"
FT   VAR_SEQ         644..651
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15944154"
FT                   /id="VSP_020385"
FT   STRAND          31..42
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   STRAND          49..63
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   STRAND          65..73
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   STRAND          79..86
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   STRAND          89..94
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   TURN            95..97
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   STRAND          98..103
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   STRAND          106..111
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   HELIX           115..128
FT                   /evidence="ECO:0007829|PDB:2OQB"
FT   HELIX           143..154
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           157..165
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           167..179
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           180..183
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   TURN            184..186
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          188..193
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          195..197
FT                   /evidence="ECO:0007829|PDB:3B3G"
FT   HELIX           198..205
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          209..215
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           219..229
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   TURN            233..235
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          236..241
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   TURN            243..245
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          252..257
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           261..264
FT                   /evidence="ECO:0007829|PDB:3B3J"
FT   TURN            265..267
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           269..275
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           276..279
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          280..288
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          290..298
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           301..311
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           312..314
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           325..327
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           328..336
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          340..342
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          354..359
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   TURN            360..362
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   HELIX           365..368
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          369..378
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          383..397
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          402..406
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          410..412
FT                   /evidence="ECO:0007829|PDB:3B3J"
FT   STRAND          418..429
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          434..444
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   TURN            445..447
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          448..457
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   TURN            458..460
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          463..469
FT                   /evidence="ECO:0007829|PDB:3B3F"
FT   STRAND          474..477
FT                   /evidence="ECO:0007829|PDB:3B3J"
SQ   SEQUENCE   651 AA;  70341 MW;  2C71ED2D8E1BE12F CRC64;
     MAAAAATAVG PGAGSAGVAG PGGAGPCATV SVFPGARLLT IGDANGEIQR HAEQQALRLE
     VRAGPDAAGI ALYSHEDVCV FKCSVSRETE CSRVGRQSFI ITLGCNSVLI QFATPHDFCS
     FYNILKTCRG HTLERSVFSE RTEESSAVQY FQFYGYLSQQ QNMMQDYVRT GTYQRAILQN
     HTDFKDKIVL DVGCGSGILS FFAAQAGARK IYAVEASTMA QHAEVLVKSN NLTDRIVVIP
     GKVEEVSLPE QVDIIISEPM GYMLFNERML ESYLHAKKYL KPSGNMFPTI GDVHLAPFTD
     EQLYMEQFTK ANFWYQPSFH GVDLSALRGA AVDEYFRQPV VDTFDIRILM AKSVKYTVNF
     LEAKEGDLHR IEIPFKFHML HSGLVHGLAF WFDVAFIGSI MTVWLSTAPT EPLTHWYQVR
     CLFQSPLFAK AGDTLSGTCL LIANKRQSYD ISIVAQVDQT GSKSSNLLDL KNPFFRYTGT
     TPSPPPGSHY TSPSENMWNT GSTYNLSSGV AVAGMPTAYD LSSVIAGGSS VGHNNLIPLA
     NTGIVNHTHS RMGSIMSTGI VQGNRVAGPW AGDLPPGLRT RSSYQWGPGR LRGHAGSSVP
     MTCPTGSSGA QGGGGSSSAH YAVNNQFTMG GPAISMASPM SIPTNTMHYG S
//
